Vystar Corporation reported $20.9 million in annual sales and an $8.3 million net loss for the year ending Dec. 31, 2020. Sales were $7.3 million higher than 2019. “The COVID-19 pandemic has raised awareness of airborne disease transmission and consumers’ desire to reduce their risk of infection through the use of air purifiers,” Vystar told…
Vystar Reports Sales Increase & Greater RxAir 400 Manufacturing Capacity
More from ProductMore posts in Product »
- US Patent Issued 2024 – US 12178927 B2 “Gasper knob sanitization”
- US Patent Issued 2024 – US 12178929 B2 “Display module and electronic device”
- US Patent Application – US 20240424158 A1 “Instant-on Handheld Sanitizer”
- US Patent Application – US 20240424157 A1 “UV STERILIZATION SYSTEM AND DEVICE AND RELATED METHODS”
- US Patent Application – US 20240415993 A1 “UVC Sterilization Chamber”